Drug recall: Voluntary Nationwide Recall: Tydemy (Lupin July)

Sep. 2023Important Notices
Lupin Pharmaceuticals Inc. has recalled two lots of Tydemy™ (Drospirenone, Ethinyl Estradiol and Levomefolate Calcium Tablets 3 mg/0.03 mg/0.451 mg and Levomefolate Calcium Tablets 0.451 mg) because they did not pass stability testing, which could impact the effectiveness of the product. Taking an ineffective product could potentially result in unexpected pregnancy. Read the full text of the voluntary Tydemy recall.

Recent Announcements

UPMC Dental Advantage celebrates 15-years of growth

From pilot program to now serving all product lines
Jan. 2026What's New

ACA Risk Adjustment Claims Submission Announcement

Notice: Submit your claims for ACA members
Jan. 2026Important Notices

Register for the Oral Health in Your Pediatric Office CME - accredited webinar

Please join us for a live, CME-accredited webinar on Wednesday, March 11 from noon to 1 p.m. that will provide an overview of oral health in your pediatric office. Providers with a(n) MD/DO, PA, CRNP, RN, or LPN may also apply for topical fluoride certification after completion of this course.
Jan. 2026Education/Webinars